Lack of association between adiponectin levels and atherosclerosis in mice

Andrea R. Nawrocki, Susanna M. Hofmann, Daniel Teupser, Joshua E. Basford, Jorge L. Durand, Linda A. Jelicks, Connie W. Woo, George Kuriakose, Stephen M. Factor, Herbert B. Tanowitz, David Y. Hui, Ira Tabas, Philipp E. Scherer

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Objective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models.

Original languageEnglish (US)
Pages (from-to)1159-1165
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume30
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Adiponectin
Atherosclerosis
Peroxisome Proliferator-Activated Receptors
LDL Receptors
Atherosclerotic Plaques
Cardiovascular System
Adipocytes
Knockout Mice
Causality
Aorta
Insulin Resistance
Rodentia
Anti-Inflammatory Agents
Cardiovascular Diseases
Cholesterol
Phenotype
Liver

Keywords

  • Adiponectin
  • Atherosclerosis
  • Diabetes mellitus
  • Insulin resistance
  • Metabolism low-density lipoprotein receptor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nawrocki, A. R., Hofmann, S. M., Teupser, D., Basford, J. E., Durand, J. L., Jelicks, L. A., ... Scherer, P. E. (2010). Lack of association between adiponectin levels and atherosclerosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(6), 1159-1165. https://doi.org/10.1161/ATVBAHA.109.195826

Lack of association between adiponectin levels and atherosclerosis in mice. / Nawrocki, Andrea R.; Hofmann, Susanna M.; Teupser, Daniel; Basford, Joshua E.; Durand, Jorge L.; Jelicks, Linda A.; Woo, Connie W.; Kuriakose, George; Factor, Stephen M.; Tanowitz, Herbert B.; Hui, David Y.; Tabas, Ira; Scherer, Philipp E.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 30, No. 6, 06.2010, p. 1159-1165.

Research output: Contribution to journalArticle

Nawrocki, AR, Hofmann, SM, Teupser, D, Basford, JE, Durand, JL, Jelicks, LA, Woo, CW, Kuriakose, G, Factor, SM, Tanowitz, HB, Hui, DY, Tabas, I & Scherer, PE 2010, 'Lack of association between adiponectin levels and atherosclerosis in mice', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 6, pp. 1159-1165. https://doi.org/10.1161/ATVBAHA.109.195826
Nawrocki, Andrea R. ; Hofmann, Susanna M. ; Teupser, Daniel ; Basford, Joshua E. ; Durand, Jorge L. ; Jelicks, Linda A. ; Woo, Connie W. ; Kuriakose, George ; Factor, Stephen M. ; Tanowitz, Herbert B. ; Hui, David Y. ; Tabas, Ira ; Scherer, Philipp E. / Lack of association between adiponectin levels and atherosclerosis in mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2010 ; Vol. 30, No. 6. pp. 1159-1165.
@article{121f8fb3ab444053a4dce69f3de7ae36,
title = "Lack of association between adiponectin levels and atherosclerosis in mice",
abstract = "Objective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models.",
keywords = "Adiponectin, Atherosclerosis, Diabetes mellitus, Insulin resistance, Metabolism low-density lipoprotein receptor",
author = "Nawrocki, {Andrea R.} and Hofmann, {Susanna M.} and Daniel Teupser and Basford, {Joshua E.} and Durand, {Jorge L.} and Jelicks, {Linda A.} and Woo, {Connie W.} and George Kuriakose and Factor, {Stephen M.} and Tanowitz, {Herbert B.} and Hui, {David Y.} and Ira Tabas and Scherer, {Philipp E.}",
year = "2010",
month = "6",
doi = "10.1161/ATVBAHA.109.195826",
language = "English (US)",
volume = "30",
pages = "1159--1165",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Lack of association between adiponectin levels and atherosclerosis in mice

AU - Nawrocki, Andrea R.

AU - Hofmann, Susanna M.

AU - Teupser, Daniel

AU - Basford, Joshua E.

AU - Durand, Jorge L.

AU - Jelicks, Linda A.

AU - Woo, Connie W.

AU - Kuriakose, George

AU - Factor, Stephen M.

AU - Tanowitz, Herbert B.

AU - Hui, David Y.

AU - Tabas, Ira

AU - Scherer, Philipp E.

PY - 2010/6

Y1 - 2010/6

N2 - Objective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models.

AB - Objective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models.

KW - Adiponectin

KW - Atherosclerosis

KW - Diabetes mellitus

KW - Insulin resistance

KW - Metabolism low-density lipoprotein receptor

UR - http://www.scopus.com/inward/record.url?scp=77952887207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952887207&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.109.195826

DO - 10.1161/ATVBAHA.109.195826

M3 - Article

C2 - 20299691

AN - SCOPUS:77952887207

VL - 30

SP - 1159

EP - 1165

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -